Biosimilars Market: Can "Asia-Pacific Hubs" Dominate 2026...

a adăugat un sunet Health

2026-01-20 13:26:06 -

A defining 2026 milestone for the industry is the rise of the Asia-Pacific region as the "Global Engine" for biosimilar production. In 2026, the market is identifying South Korea, India, and China as the world's primary exporters of high-quality biosimilars, with these three nations accounting for over 35% of the global pipeline. This 2026 strategy is vital because it leverages lower labor...

0 Commentarii 0 Distribuiri 76 Views 0 previzualizare